Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system

Fig. 3

Kaplan-Meier estimation for overall survival (n = 87) after first radioembolization, groups of patients with survival benefit (score of 0/1) vs. no survival benefit (score of 2/3). Since all patients had died by the time of analysis, no censored patients occur in the graph. Median OS was 10.4 months (score 0 or 1) vs. 5.1 months (score 2 or 3), p < 0.001

Back to article page